Brenda O Brooks

Brenda T. Brooks serves as a Contracting Officer responsible for managing the acquisition lifecycle for medical laboratory services and related technical support. In this role, she ensures compliance with federal procurement regulations while advancing mission-critical healthcare diagnostics capabilities. Her portfolio is exclusively focused on professional services tied to clinical testing, specimen analysis, and laboratory operations, requiring deep familiarity with technical specifications, quality control standards, and regulatory frameworks such as CLIA and CAP. She executes acquisitions through competitive sealed bidding and negotiated procedures, prioritizing performance-based contract structures and outcome-driven deliverables. While no specific contractor relationships are currently identifiable in the available data, her procurement activity consistently engages qualified vendors with demonstrated expertise in clinical laboratory operations, including analytical instrumentation, workflow automation, and data management systems. She maintains a vendor-neutral approach, evaluating proposals based on technical merit, past performance, and compliance with federal quality benchmarks rather than favoring any single entity. Brenda’s contracting patterns reflect a strong preference for full and open competition, with 100% of her awards issued without set-aside designations. This indicates a strategic focus on maximizing market competition and ensuring access to the broadest possible pool of qualified providers, rather than reserving opportunities for specific socioeconomic categories. Her approach aligns with agency priorities that emphasize efficiency and technical excellence over socioeconomic targeting. Her primary and exclusive NAICS focus is 621511—Medical Laboratories—underscoring her specialization in procuring diagnostic testing services, pathology support, reference lab functions, and associated clinical analytics. She routinely manages contracts for high-complexity testing, molecular diagnostics, and laboratory information systems, requiring precise understanding of scientific validation protocols and regulatory compliance. Her domain expertise ensures that acquisitions meet stringent healthcare quality standards while supporting timely, accurate patient care outcomes.